 Customers |
| Chemistry – Pharmacy |
 Back |
  |
 is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer is represented around the world by 350 companies with 106.200 employees. The revenues in 2007 were more than 32 billions euro. Global headquarters are in Leverkusen, Germany.
Business operations are the responsibility of the subgroups:
Bayer HealthCare makes an important contribution to human and animal health with its innovative products and by researching new therapeutic approaches. The subgroup has four operating divisions: Bayer Schering Pharma* (prescription medicines), Consumer Care (over-the-counter medicines and nutritional supplements), Diabetes Care (blood glucose monitoring systems, Animal Health (veterinary medicines and grooming products)
Bayer CropScience is a world leader in the areas of crop protection, pest control, seeds and plant biotechnology. As a partner in the production of high-quality food, feed and fiber, the company offers comprehensive solutions for modern, sustainable agriculture and non-agricultural applications.
Bayer MaterialScience is one of the world’s leading manufacturers of polymers and high-quality plastics. Apart from its polycarbonates and polyurethanes, this company’s offering also includes innovative developments in the fields of coatings, adhesives, insulating materials and sealants. Principal customers are the automotive and construction industries, the electrical/electronics sector and manufacturers of sports and leisure articles, packaging and medical equipment. |  |
 Sanofi-aventis is the world’s third largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, Sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic disorders, central nervous system, internal medicine, and vaccines. | |
Sasol Germany is an
important part of Sasol's chemical businesses and forms part of the Sasol
Olefins& Surfactans business. Sasol Germany produces surfactants and
surfactant intermediates such as alcohols and ethylene oxide, as well as
inorganic speciality chemicals including high-purity aluminas and
oleochemicals. The chemicals processing industries uses these products in the
manufacture, among others, of additives for plastics, catalysts, cosmetics,
detergents, and high performance abrasives. We work closely with customers, adapting products in line with the latest
research and market developments.
With a workforce of 1,500 employees, we generate annual sales of
about € 1 billion. Three production sites located in Brunsbüttel, Marl, and Witten form part
of the company, in addition to our headoffice in Hamburg.
Sasol Germany forms
part of the Sasol Olefins & Surfactants (O&S) Division. Businesses are
positioned globally, with production sites located e.g. in Germany (Sasol Germany),
Italy (Sasol Italy), the U.S.
(Sasol North America), and China
(Sasol China). | |
 Sirona is a world-leading manufacturer of dental equipment and has played a high-profile role in efforts to promote technical progress and thereby treatment cost-efficiency in dental surgeries and laboratories. Its four divisions - Treatment Centres, Imaging Systems, Dental CAD/CAM Systems, and Handpieces and Sterilizers – are positioned on expanding markets and enjoying commensurately handsome growth. | |
 Süd-Chemie is a highly-innovative, listed, specialty chemicals company headquartered in Munich. With its two divisions of Adsorbents and Catalysts, the Süd-Chemie Group, which has around 4,800 employees, generates total sales of approx. 1 billion euros. Süd-Chemie holds an extremely strong position on global markets, almost 80 percent of Group sales being realised with customers outside Germany. It systematically exploits the potential offered by fast-growing regions, notably in Southeast Asia and the Middle East. | |
 UCB is a leading, global, fast growing biopharmaceutical company, specialising in the fields of central nervous system disorders, allergy and respiratory disease, immune and inflammatory disorders, and oncology. UCB employs over 8,500 people operating in over 40 countries. | |
|
|
Case Studies
Publications
